Baird Medical Secures Regulatory Approvals in Pakistan and Vietnam
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a leader in Microwave Ablation (MWA) technology, has achieved significant regulatory milestones with official product registrations from the Medical Device Board (MDB) of Pakistan and the Ministry of Health of Vietnam. These approvals represent a vital step in Baird Medical's global expansion strategy, aimed at increasing its market presence in Southeast Asia.
Baird Medical's Launch in Pakistan
In Pakistan, Baird Medical successfully executed an official product launch at the Armed Forces Institute of Radiology & Imaging (AFIRI), led by Dr. Raza Raheem, a renowned expert in the field of interventional radiology. This launch marks a crucial entrance for BDMD into the local healthcare sector, aligning with the company’s objectives to enhance patient care through advanced medical technologies.
Significant Expansion in Vietnam
The acquisition of registration approval in Vietnam signifies an important expansion of BDMD's operational footprint in Southeast Asia. These regulatory achievements underscore the Company's commitment to expedite its global commercialization efforts, further establishing its presence in high-growth markets.
"Securing these approvals in Pakistan and Vietnam is a pivotal step in our international expansion," said Mrs. Haimei Wu, Chairwoman of Baird Medical. "By entering these high-growth markets, we are empowering local clinicians with advanced, minimally invasive tools to improve outcomes for patients."
About Baird Medical
Baird Medical is a forward-thinking medical device company focused on minimally invasive diagnostics and treatment. The company is dedicated to the research and development of innovative medical solutions, aiming to enhance patient outcomes through precise technology and advanced diagnostic tools. Baird Medical’s products have been utilized in over 30 prestigious hospitals across the United States, maintaining its status as a leader in China for thyroid microwave ablation devices.
- FDA 510(k)-certified medical device company
- Commercial presence in over 20 countries
- Strategic collaborations with leading academic institutions
Looking Ahead: Forward-Looking Statements
This announcement includes forward-looking statements pertaining to Baird Medical's future performance and operational strategy. These statements may involve risks and uncertainties, which could lead to actual results differing significantly from those anticipated. Investors are advised to consider these factors carefully before making investment decisions related to BDMD.
Contact Information
For further inquiries, please contact:
Eric Huang, PR Liaison
Baird Medical Investment Holdings Ltd.
Phone: +1 (888) 508-6228
Email: info@bairdmedical.com